Concert Pharmaceuticals Inc. Shares Close the Week 20.6% Lower - Weekly Wrap

The company saw its shares close the week 20.6% lower than last week, with trading volume higher than its 30 day average.

Mar 26, 2021 by Kwhen Finance Editors

Concert Pharmaceuticals Inc. Shares Close the Week 20.6% Lower - Weekly Wrap
Concert Pharmaceuticals Inc. shares closed this week 20.6% lower than it did at the end of last week. The stock is currently down 61.3% year-to-date, down 47.7% over the past 12 months, and down 62.2% over the past five years. This week, the Dow Jones Industrial Average rose 1.4%, and the S&P 500 rose 1.7%.

Trading Activity

  • Shares traded as high as $6.30 and as low as $4.59 this week.
  • Shares closed 6e+1% below its 52-week high and 7% above its 52-week low.
  • Trading volume this week was 113.2% higher than the 10-day average and 261.9% higher than the 30-day average.
  • Beta, a measure of the stock’s volatility relative to the overall market stands at 1.3.

Technical Indicators

  • The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
  • MACD, a trend-following momentum indicator, indicates a downward trend.
  • The stock closed below its Bollinger band, indicating it may be oversold.

Market Comparative Performance

  • The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis
  • The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis
  • The company share price lags the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis
NameDoD %ΔYTD %Δ1 Yr %52-Week H %52-Week L %
Concert Pharmaceuticals Inc.-1.3-61.3-47.7-62.79.8
Dow Jones Industrial Average1.48.649.8-1.461.3
S&P 500 Index1.66.354.0-1.562.9
Health Care1.93.038.0-3.841.1

Peer Group Comparative Performance

  • The company's stock price performance year-to-date lags the peer average by -520.3%
  • The company's stock price performance over the past 12 months lags the peer average by -146.5%
NameMKT CAP (USD)P/EYTD %Δ1 Yr %Δ52-Week H %52-Week L %
Concert Pharmaceuticals Inc.CNCE0-61.3-47.7-62.79.8
Peer AvgN/A-7.514.6102.5-17.9126.3
AbbVie Inc.ABBV41.10.153.6-8.153.4
Jazz Pharmaceuticals PlcJAZZ39.82.073.7-6.775.4
GW Pharmaceuticals PLC Sponsored ADRGWPH-118.288.7154.0-0.3169.2
Ardelyx Inc.ARDX0-3.411.8-25.824.6
Trevena Inc.TRVN0-14.5219.6-48.9308.7

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.

Was this content valuable for you?

Tags: